USANA HEALTH SCIENCES INC
For the period ended May 5, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 5, 2026 · Filed May 5, 2026
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter ended | ||
|---|---|---|
| April 04, 2026 | March 29, 2025 | |
| Net earnings attributable to USANA (GAAP) | $7,515 | $9,402 |
| Earnings per common share - Diluted (GAAP) | $0.41 | $0.49 |
| Weighted Average common shares outstanding - Diluted | 18,411 | 19,085 |
| Adjustment to net earnings: | ||
| Transaction, integration and transition costs - Hiya | $239 | $577 |
| Inventory step-up - Hiya | — | 582 |
| Amortization of intangible assets - Hiya | 4,455 | 4,455 |
| Adjustments to net earnings attributable to noncontrolling interest | (942) | (1,066) |
| Income tax effect of adjustments to net earnings | — | (4) |
| Adjusted net earnings attributable to USANA | $11,267 | $13,946 |
| Adjusted earnings per common share - Diluted | $0.61 | $0.73 |
| Weighted average common shares outstanding - Diluted | 18,411 | 19,085 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.